List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 6 studies with search of:   "Lurtotecan"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer
Conditions: SCLC;   Carcinoma, Small Cell
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
2 Completed Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
3 Active, not recruiting Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: lurtotecan liposome
4 Active, not recruiting Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: lurtotecan liposome
5 Active, not recruiting Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: lurtotecan liposome
6 Active, not recruiting Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Conditions: Head and Neck Cancer;   Lung Cancer;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cisplatin;   Drug: lurtotecan liposome

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services